Certified by Founder Lodge 
                                        
                                        EQT Life Sciences
 
                                                 Netherlands  -  Amsterdam, North Holland 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $20,000,000
                                            22 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies.
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   AstronauTx | 
                                                            October, 09 ,2023 | Series A | $58,462,000 | 
   Atalanta Therapeutics | 
                                                            January, 29 ,2025 | Series B | $75,000,000 | 
   Shinobi Therapeutics | 
                                                            December, 13 ,2023 | Series A | $51,000,000 | 
   FundamentalVR | 
                                                            August, 11 ,2022 | Series B | $20,000,000 | 
   LUMA Vision | 
                                                            December, 19 ,2023 | Series A | $22,000,000 | 
   xilis | 
                                                            July, 13 ,2022 | Series A | $89,000,000 | 
   Atalanta Therapeutics | 
                                                            January, 29 ,2025 | Series B | $75,000,000 | 
   Mosanna Therapeutics | 
                                                            June, 10 ,2025 | Series A | $80,000,000 | 
   Mosanna Therapeutics | 
                                                            June, 10 ,2025 | Series A | $80,000,000 | 
   QurAlis | 
                                                            March, 10 ,2023 | Series B | $88,000,000 | 
   Cyted Health | 
                                                            September, 03 ,2025 | Series B | $44,000,000 | 
   Evommune | 
                                                            April, 27 ,2023 | Series B | $50,000,000 | 
   AstronauTx | 
                                                            October, 09 ,2023 | Series A | $58,462,000 | 
   Tubulis GmbH | 
                                                            October, 16 ,2025 | Series C | $359,197,300 | 
   Shinobi Therapeutics | 
                                                            December, 13 ,2023 | Series A | $51,000,000 | 
   Electra Therapeutics | 
                                                            October, 22 ,2025 | Series C | $183,000,000 | 
   LUMA Vision | 
                                                            December, 19 ,2023 | Series A | $22,000,000 | 
   Atalanta Therapeutics | 
                                                            January, 29 ,2025 | Series B | $75,000,000 | 
   Mosanna Therapeutics | 
                                                            June, 10 ,2025 | Series A | $80,000,000 | 
   Cyted Health | 
                                                            September, 03 ,2025 | Series B | $44,000,000 | 
   Tubulis GmbH | 
                                                            October, 16 ,2025 | Series C | $359,197,300 | 
   Electra Therapeutics | 
                                                            October, 22 ,2025 | Series C | $183,000,000 | 
                                                
  AstronauTx
  Atalanta Therapeutics
  Shinobi Therapeutics
  FundamentalVR
  LUMA Vision
  xilis
  Mosanna Therapeutics
  QurAlis
  Cyted Health
  Evommune
  Tubulis GmbH
  Electra Therapeutics
Cherry Ventures
 
                                            
Blue Bear Capital
 
                                            
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)